Cancer-associated thrombosis in the pediatric setting: A chat with Prof. Gili Kenet
Prof. Gili Kenet is a Pediatric Hematologist, Professor and Chair of the Haematology Department at the Sackler Medical...
Focus on: Pediatrics
Dabigatran etexilate and rivaroxaban for the treatment of acute venous thromboembolism in children: options for direct oral anticoagulant treatment in pediatric patients
Introduction Venous thromboembolism (VTE) is a rare condition in pediatric patients that is being increasingly...
Cancer-associated thrombosis in children
Venous thromboembolism (VTE) is one of the leading causes of death in adult cancer patients and represents a challenge...
An update on the status of direct oral anticoagulants in children
Introduction Once considered a condition of adults or the elderly, venous thromboembolism (VTE) is now being recognized...
Developmental hemostasis and its relevance to pediatric thrombosis
The coagulation system of neonates and children evolves with age, as evidenced by marked physiological differences in...
Arterial thrombosis and pediatric cancer- should cancer associated pediatric stroke be studied?
While knowledge of arterial thromboembolism prevalence and risk factors among adult cancer patients is currently...
Should we test pediatric cancer patients for thrombophilia: NO
Cancer is the second most common cause of death in children in developed countries. Fortunately, survival rates have...
Should we test pediatric cancer patients for thrombophilia: YES
Venous thromboembolism (VTE) in children is a rare disease usually as a secondary complication of primary underlying...